Table 2 The mortality and medical costs of carbapenem-resistant KP(CR-KP) and carbapenem-susceptible KP (CS-KP) groups.
CR-KP (n = 71) | CS-KP (n = 71) | Z/χ 2 | p | |
|---|---|---|---|---|
Mortality (%) | 28/71 (39.4%) | 16/71 (25.7%) | 4.74 | 0.03 |
Total costs (¥) | 162618 (9098–1078466) | 104225 (18145–529492) | −2.87 | >0.001 |
Medical examination | 6822 (174–29670) | 5077 (284–28496) | −1.09 | 0.27 |
Medical test costs (¥) | 14124 (1894–74174) | 8434 (846–46706) | −2.93 | >0.001 |
Total drug costs (¥) | 78579 (965–442989) | 38651.5 (8300–222058) | −2.96 | >0.001 |
Anti-infective drug costs (¥) | 19755 (63–243121) | 7171 (0–63506) | −3.64 | >0.001 |
Total hospital stay days | 37 (4–227) | 28 (7–149) | −2.33 | 0.02 |
